Telix Pharmaceuticals: Acquires Optimal Tracers

Telix Pharmaceuticals Acquires Optimal Tracers

  • Telix Pharmaceuticals (TLX) enters an agreement with Northern California PET Imaging Center to acquire radiochemistry specialist Optimal Tracers
  • The company believes the acquisition will “bolster” its in-house radiochemistry development capability by adding a highly-skilled team and establishing a US-based lab
  • Telix will also own Optimal Tracer’s facility, which has a radiation and pharmaceutical manufacturing licence to support pre-clinical and clinical research
  • Optimal Tracer’s CEO, Ruth Tesar, says she’s looking forward to providing Telix with the radiochemistry knowledge and experience to contribute to its future success
  • TLX shares are trading at $6.78 at 2:49 pm AEDT
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Brink’s Strengthens Position with $6.6B NCR Acquisition

Brink's expands its services through strategic acquisition of NCR's Atleos.Highlights: Brink's acquires NCR Atleos for $6.6 billion.The deal...

Barclays Strengthens Blockchain Payments Platform Discussions

Bank explores blockchain vendors for enhanced payment solutions.Highlights: Barclays explores blockchain technology for payments.Bank engages with various vendors...

Lloyds Tightens Bank Account Opening Process in Branches

The bank limits account openings amidst ongoing service updates.Highlights: Lloyds will restrict opening some bank accounts in branches.The...

Jack Dorsey’s Block to Lay Off 4,000 Employees as AI Era Advances

Significant workforce reduction reflects shifts in technology focus.Highlights: Block announces 4,000 layoffs amid evolving AI landscape.The decision comes...